Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Early measurement of selenoprotein 1 (SEPP1) after cardiac surgery shows potential for identifying patients at risk of myocardial injury. SEPP1 levels correlate with established cardiac injury markers, aiding prognostication.
Area Of Science
- Cardiology
- Biomarker Research
- Cardiac Surgery
Background
- Perioperative myocardial disease prediction is vital for advancing cardiac surgery treatment.
- Developing reliable biomarkers for prognostication and prediction is crucial.
- Selenoprotein 1 (SEPP1) is explored as a potential biomarker for myocardial injury.
Purpose Of The Study
- To investigate the role of circulating SEPP1 as a biomarker for myocardial injury risk after cardiac surgery.
- To assess the correlation of SEPP1 levels with established cardiac injury markers.
Main Methods
- Prospective monocentric study involving 45 cardiac surgery patients.
- Circulating SEPP1 levels measured via ELISA before and at 4, 8, and 12 hours after cardiopulmonary bypass (CPB).
- Correlation analysis with creatine kinase-MB (CK-MB), high-sensitivity cardiac troponin (Hs-c troponin), CPB time, and cross-clamp time.
Main Results
- SEPP1 levels at 4 hours post-surgery strongly correlated with CK-MB at 48 and 72 hours.
- Significant correlations were observed between 4-hour SEPP1 and Hs-c troponin at 24, 48, and 72 hours.
- SEPP1 levels also correlated with cardiopulmonary bypass and cross-clamp durations.
Conclusions
- Early SEPP1 measurement post-cardiac surgery shows promise for identifying patients at risk of myocardial injury.
- SEPP1 may serve as an early predictive biomarker in the perioperative setting.
- Further research can validate SEPP1's role in managing cardiac surgery patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...